Sage Journals: Discover world-class research

Open access

Review article

First published 2019

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer

Jonathan A. Ledermann, Eric Pujade-Lauraine

Therapeutic Advances in Medical Oncology

Free access

Review article

First published 2014-9

Treatment options in recurrent ovarian cancer: latest evidence and clinical potential

Daniela Luvero, Andrea Milani, Jonathan A. Ledermann

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2016-9

The Current Status of PARP Inhibitors in Ovarian Cancer

Jennifer McLachlan, Angela George, Susana Banerjee

Tumori Journal

Retricted access

Research article

First published 2011-09

Radiation therapy is a treatment to be considered for recurrent epithelial ovarian cancer after chemotherapy

Shin-Wha Lee, Sang-Min Park, Yong-Man Kim [...]

Tumori Journal

Free access

Research article

First published 2006-7

Pre-Treatment Prediction of Chemoresistance in Second-Line Chemotherapy of Ovarian Carcinoma: Value of Serological Tumor Marker Determination (Tetranectin,YKL-40,CASA,CA 125)

B. Gronlund, E.V.S. Høgdall, I.J. Christensen [...]

The International Journal of Biological Markers

Open access

Research article

First published 2022

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas

Roberta Affatato, Michela Chiappa, Federica Guffanti [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2004-11

A Phase II Study of Liposomal Doxorubicin in Recurrent Epithelial Ovarian Carcinoma

Carmela Arcuri, Roberto Sorio, Germana Tognon [...]

Tumori Journal

Retricted access

Research article

First published 2021-08

Feasibility of Bone Marrow Mesenchymal Stem Cell-Mediated Synthetic Radiosensitive Promoter-Combined Sodium Iodide Symporter for Radiogenetic Ovarian Cancer Therapy

Shuo Shi, Fei Li, Liangcai Wu [...]

Human Gene Therapy

Open access

Research article

First published 2023

Oxaliplatin prior to PARP inhibitor in BRCA-mutated ovarian cancer

Maria Ornella Nicoletto, Alessandra Baldoni, Francesco Cavallin [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2010-11

Positive experience of Intraperitoneal Chemotherapy followed by Intravenous Chemotherapy in Heavily Pretreated Patients with Suboptimal Residual Ovarian Cancer and Primary Peritoneal Cancer

Maria Ornella Nicoletto, Maurizia Dalla Palma, Martin E Donach [...]

Tumori Journal

Search results